HR890-119

Introduced

To amend title 35, United States Code, to prevent double patenting, and for other purposes.

119th Congress Introduced Jan 31, 2025

Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.

Summary

What This Bill Does

The bill reduces a appropriation, grant, reporting req provision: 2. Prevention of double patenting Section 253 of title 35, United States Code, is amended by adding at the end the following: Except as provided in paragraph (2). It relies on appropriations, grants, and reporting requirements. The main policy areas are Healthcare.

Who Benefits and How

The available clause analysis does not identify a specific beneficiary group.

Who Bears the Burden and How

No clear private burden is identified from the available clause analysis; implementing agencies may still take on administrative work.

Key Provisions

  • Reduces a appropriation, grant, reporting req provision: 2. Prevention of double patenting Section 253 of title 35, United States Code, is amended by adding at the end the following: Except as provided in paragraph (2)...

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for primary purpose and policy domains.

At a Glance

What This Bill Does

The bill reduces a appropriation, grant, reporting req provision: 2. Prevention of double patenting Section 253 of title 35, United States Code, is amended by adding at the end the following: Except as provided in paragraph (2).

Key Policy Areas

Healthcare

Primary Purpose

The bill reduces a appropriation, grant, reporting req provision: 2. Prevention of double patenting Section 253 of title 35, United States Code, is amended by adding at the end the following: Except as provided in paragraph (2).

Policy Domains

Healthcare

Legislative Progress

Introduced
Introduced Committee Passed
Jan 31, 2025

Mr. Ryan introduced the following bill; which was referred to …

Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Healthcare
Actor Mappings
"secretary_of_commerce"
→ Secretary of Commerce

Key Definitions

Terms defined in this bill

1 term
"Office" §HE432E3EE15F049C9950231473A137384

the United States Patent and Trademark Office

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology